ArticleFrontiers in immunology2024

Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study).

Kuniaki Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.